Publicaciones en las que colabora con RAFAEL BAÑARES CAÑIZARES (63)

2024

  1. Hepatic hemodynamic study: More than just HVPG measurement

    Gastroenterologia y Hepatologia

2023

  1. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

    JHEP Reports, Vol. 5, Núm. 3

  2. Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study

    Therapeutic Advances in Gastroenterology, Vol. 16

  3. Prognostic implications of systolic function in patients with cirrhosis

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 446-454

2022

  1. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study

    European Journal of Neurology, Vol. 29, Núm. 2, pp. 400-412

  2. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history

    United European Gastroenterology Journal, Vol. 10, Núm. 8, pp. 805-816

2021

  1. HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation

    Transplant International, Vol. 34, Núm. 11, pp. 2214-2225

  2. Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients

    Therapeutic Advances in Gastroenterology, Vol. 14

2020

  1. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

    Hepatology, Vol. 72, Núm. 6, pp. 1924-1934

  2. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients

    Liver International, Vol. 40, Núm. 9, pp. 2215-2227

  3. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort

    Journal of Hepatology, Vol. 72, Núm. 4, pp. 702-710

2019

  1. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients

    Liver Transplantation, Vol. 25, Núm. 8, pp. 1177-1186

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

2017

  1. Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

    Journal of Hepatology, Vol. 66, Núm. 6, pp. 1138-1148

  2. Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis

    Hepatology, Vol. 65, Núm. 6, pp. 2019-2030

2016

  1. Determinants of platelet count are different in patients with compensated and decompensated cirrhosis

    Liver International, Vol. 36, Núm. 2, pp. 232-239

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  3. Liver Support With Albumin Dialysis Reduces Hepatitis C Virus Viremia and Facilitates Antiviral Treatment of Severe Hepatitis C Virus Recurrence After Liver Transplantation

    Therapeutic Apheresis and Dialysis, Vol. 20, Núm. 2, pp. 189-196

2015

  1. Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy

    Clinical Gastroenterology and Hepatology, Vol. 13, Núm. 10, pp. 1846-1853.e1